Influence of titanium oxide and titanium peroxy gel on the breakdown of hyaluronan by reactive oxygen species.
The molecular events occurring at the interface between titanium and connective tissue were investigated in order to help explain the unique biocompatible properties of titanium implants and their successful osseointegration into bone tissue. In this study the influence of commercially pure titanium and titanium peroxy gels on the breakdown of the connective tissue component and serum derived factor, hyaluronan, by reactive oxygen species (ROS), produced during the insertion of an implant in vivo, was examined. Hyaluronan breakdown was monitored in vitro in the presence of a hydroxyl radical flux, generated in the presence and absence of titanium powder and discs. Parallel studies examined the breakdown of hyaluronan by hydroxyl radicals in the presence of a titanium peroxy gel, prepared by incubation of the titanium powder or discs in concentrated hydrogen peroxide. The hyaluronan degradation products were separated according to their hydrodynamic size by gel exclusion chromatography. Similarly, experiments were also performed examining the degradation of 2-deoxy-D-ribose by a hydroxyl radical flux in order to demonstrate the detrimental potential of the hydroxyl radicals and to provide a measure of the effectiveness of titanium and titanium peroxy gels as scavengers of ROS. Titanium reduced the harmful effects of the hydroxyl radicals on the breakdown of hyaluronan, presumably acting as a scavenger for the reactive species, possibly by absorbing them into its surface oxide layer, which spontaneously forms on the surface. In contrast, the formation of a titanium peroxy gel from the titanium powder or on the surface of titanium discs enhanced breakdown of both the hyaluronan chains and 2-deoxy-D-ribose. The implications of these findings with regards to the biocompatible nature of the titanium and the ability of these implants to successfully osseointegrate are discussed.
Taylor
G C
GC
Department of Basic Dental Science, Dental School, University of Wales College of Medicine, Cardiff, UK.
Waddington
R J
RJ
Moseley
R
R
Williams
K R
KR
Embery
G
G
D001672:Biocompatible Materials / Q000494:pharmacology*; D015921:Dental Implants; D003855:Deoxyribose / Q000378:metabolism; D005782:Gels; D006801:Humans; D006820:Hyaluronic Acid / Q000378:metabolism*; D066298:In Vitro Techniques; D008422:Materials Testing; D016348:Osseointegration / Q000187:drug effects / Q000502:physiology; D010545:Peroxides / Q000494:pharmacology*; D017382:Reactive Oxygen Species / Q000378:metabolism; D014025:Titanium / Q000494:pharmacology*
D001672:Biocompatible Materials; D015921:Dental Implants; D005782:Gels; D010545:Peroxides; D017382:Reactive Oxygen Species; C009495:titanium dioxide; D003855:Deoxyribose; D006820:Hyaluronic Acid; D014025:Titanium